BioUtah COVID-19 Life Sciences Survey
March 17, 2020
TIME SENSITIVE – PLEASE TAKE SURVEY
Dear Members of Utah’s Life Sciences Community,
BioUtah is taking a multi-pronged approach to support our life sciences companies, industry workforce, and communities during the COVID-19 pandemic, including:
- Working directly with the Utah State Coronavirus Task Force to identify products and resources needed in the state
- Indentifing funding sources from state and federal governments to support emergency countermeasures and other responses
- Gaining a better understanding of how our companies are impacted and how BioUtah can provide assistance
We ask you to respond to a brief survey by Friday, March 20.
Recent News
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
- Sera Prognostics Appoints Scott Gleason CFO
- Merit Medical Announces Global Operations Leadership Transition
- Utah Life Sciences Innovation Caucus Breakfast
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
